Navidea Biopharmaceuticals announced data from its Phase 3 clinical study investigating 99m-Tc-Tilmanocept (Lymphoseek) in Sentinel Lymph Node (SLN) mapping in patients with head and neck squamous ...
Today, more than 50% of new cancer cases and nearly two thirds of cancer deaths occur in low-income, lower middle-income and upper middle-income countries. By the year 2030, the developing world is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback